Background: Due to the pressing need to understand the causal and associative factors of depression among prostate cancer (PCa) patients, a comprehensive research protocol for investigating depression in prostate cancer patients is suggested as a way of furthering the collection of data in consistent and informative ways. Methods: A detailed review of a range of predictors of, and buffers against, depression, plus methods of assessing depressive symptomatology and optimum time to collect data were used to develop a model for a comprehensive research protocol. Results: A model protocol is described that includes socioeconomic, genetic, endocrinal, immunological, physiological, psychological, relationship, and socioeconomic pathways to depres...
The prevalence of depression in patients with cancer is high, especially for patients with advanced ...
Prostate cancer is the second most common type of cancer among men, being considered a cancer of the...
Background and Aims: Oncologic diseases currently have a high prevalence and present as one of the l...
Daniel O. Erim: Policy-relevant characteristics of depressive and anxiety disorders in prostate canc...
Objective In order to optimize psycho‐oncological care, studies that quantify the extent of distres...
Abstract Objective: to evaluate the prevalence of symptoms of depression among men diagnosed with p...
[[abstract]]Studies exploring the mediating and predictive factors of anxiety and depression for pro...
Objectives. To estimate the prevalence of unsuspected anxiety or depression in prostate cancer patie...
Background: The early diagnosis and treatment of depression are cancer care priorities. These priori...
Depression in men with prostate cancer is a significant and complex issue that can challenge clinici...
Purpose: Some prostate cancer (PCa) patients become clinically anxious or depressed after diagnosis ...
Objective: The incidence of prostate cancer has risen sharply in the last decade, yet knowledge abou...
PurposeAlthough demographic, clinicopathologic, and socioeconomic differences may affect treatment a...
OBJECTIVE: This study aimed to explore the psychological impact of favorable-risk prostate cancer (P...
Background: Appropriate depression care is a cancer-care priority. However, many cancer survivors li...
The prevalence of depression in patients with cancer is high, especially for patients with advanced ...
Prostate cancer is the second most common type of cancer among men, being considered a cancer of the...
Background and Aims: Oncologic diseases currently have a high prevalence and present as one of the l...
Daniel O. Erim: Policy-relevant characteristics of depressive and anxiety disorders in prostate canc...
Objective In order to optimize psycho‐oncological care, studies that quantify the extent of distres...
Abstract Objective: to evaluate the prevalence of symptoms of depression among men diagnosed with p...
[[abstract]]Studies exploring the mediating and predictive factors of anxiety and depression for pro...
Objectives. To estimate the prevalence of unsuspected anxiety or depression in prostate cancer patie...
Background: The early diagnosis and treatment of depression are cancer care priorities. These priori...
Depression in men with prostate cancer is a significant and complex issue that can challenge clinici...
Purpose: Some prostate cancer (PCa) patients become clinically anxious or depressed after diagnosis ...
Objective: The incidence of prostate cancer has risen sharply in the last decade, yet knowledge abou...
PurposeAlthough demographic, clinicopathologic, and socioeconomic differences may affect treatment a...
OBJECTIVE: This study aimed to explore the psychological impact of favorable-risk prostate cancer (P...
Background: Appropriate depression care is a cancer-care priority. However, many cancer survivors li...
The prevalence of depression in patients with cancer is high, especially for patients with advanced ...
Prostate cancer is the second most common type of cancer among men, being considered a cancer of the...
Background and Aims: Oncologic diseases currently have a high prevalence and present as one of the l...